28 related articles for article (PubMed ID: 16913725)
1. [1,2,4]Triazolo[3,4-
Murthy S; Nizi MG; Maksimainen MM; Massari S; Alaviuhkola J; Lippok BE; Vagaggini C; Sowa ST; Galera-Prat A; Ashok Y; Venkannagari H; Prunskaite-Hyyryläinen R; Dreassi E; Lüscher B; Korn P; Tabarrini O; Lehtiö L
J Med Chem; 2023 Jan; 66(2):1301-1320. PubMed ID: 36598465
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antiproliferative and antitrypanosomal activities, and DNA binding of novel 6-amidino-2-arylbenzothiazoles.
Racané L; Rep V; Kraljević Pavelić S; Grbčić P; Zonjić I; Radić Stojković M; Taylor MC; Kelly JM; Raić-Malić S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1952-1967. PubMed ID: 34455887
[TBL] [Abstract][Full Text] [Related]
3. Dynamically Shaping Chaperones. Allosteric Modulators of HSP90 Family as Regulatory Tools of Cell Metabolism in Neoplastic Progression.
Sanchez-Martin C; Serapian SA; Colombo G; Rasola A
Front Oncol; 2020; 10():1177. PubMed ID: 32766157
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents.
Osmaniye D; Levent S; Karaduman AB; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 May; 23(5):. PubMed ID: 29724002
[TBL] [Abstract][Full Text] [Related]
5. Thymine functionalised porphyrins, synthesis and heteromolecular surface-based self-assembly.
Slater AG; Hu Y; Yang L; Argent SP; Lewis W; Blunt MO; Champness NR
Chem Sci; 2015 Feb; 6(2):1562-1569. PubMed ID: 29560243
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.
Zaware N; Kisliuk R; Bastian A; Ihnat MA; Gangjee A
Bioorg Med Chem Lett; 2017 Apr; 27(7):1602-1607. PubMed ID: 28258797
[TBL] [Abstract][Full Text] [Related]
7. First Structural View of a Peptide Interacting with the Nucleotide Binding Domain of Heat Shock Protein 90.
Raman S; Singh M; Tatu U; Suguna K
Sci Rep; 2015 Nov; 5():17015. PubMed ID: 26599366
[TBL] [Abstract][Full Text] [Related]
8. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.
Brandvold KR; Morimoto RI
J Mol Biol; 2015 Sep; 427(18):2931-47. PubMed ID: 26003923
[TBL] [Abstract][Full Text] [Related]
9. Biological activities of 2-mercaptobenzothiazole derivatives: a review.
Azam MA; Suresh B
Sci Pharm; 2012; 80(4):789-823. PubMed ID: 23264933
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1.
Spinks D; Ong HB; Mpamhanga CP; Shanks EJ; Robinson DA; Collie IT; Read KD; Frearson JA; Wyatt PG; Brenk R; Fairlamb AH; Gilbert IH
ChemMedChem; 2011 Feb; 6(2):302-8. PubMed ID: 21275054
[TBL] [Abstract][Full Text] [Related]
11. Purine-scaffold Hsp90 inhibitors.
Taldone T; Chiosis G
Curr Top Med Chem; 2009; 9(15):1436-46. PubMed ID: 19860732
[TBL] [Abstract][Full Text] [Related]
12. New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.
Li Y; Zhang T; Schwartz SJ; Sun D
Drug Resist Updat; 2009; 12(1-2):17-27. PubMed ID: 19179103
[TBL] [Abstract][Full Text] [Related]
13. Discovery and development of heat shock protein 90 inhibitors.
Taldone T; Sun W; Chiosis G
Bioorg Med Chem; 2009 Mar; 17(6):2225-35. PubMed ID: 19017562
[TBL] [Abstract][Full Text] [Related]
14. New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile.
Lambertucci C; Cristalli G; Dal Ben D; Kachare DD; Bolcato C; Klotz KN; Spalluto G; Volpini R
Purinergic Signal; 2007 Sep; 3(4):339-46. PubMed ID: 18404447
[TBL] [Abstract][Full Text] [Related]
15. 7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors.
Zhang L; Fan J; Vu K; Hong K; Le Brazidec JY; Shi J; Biamonte M; Busch DJ; Lough RE; Grecko R; Ran Y; Sensintaffar JL; Kamal A; Lundgren K; Burrows FJ; Mansfield R; Timony GA; Ulm EH; Kasibhatla SR; Boehm MF
J Med Chem; 2006 Aug; 49(17):5352-62. PubMed ID: 16913725
[TBL] [Abstract][Full Text] [Related]
16. Orally active purine-based inhibitors of the heat shock protein 90.
Biamonte MA; Shi J; Hong K; Hurst DC; Zhang L; Fan J; Busch DJ; Karjian PL; Maldonado AA; Sensintaffar JL; Yang YC; Kamal A; Lough RE; Lundgren K; Burrows FJ; Timony GA; Boehm MF; Kasibhatla SR
J Med Chem; 2006 Jan; 49(2):817-28. PubMed ID: 16420067
[TBL] [Abstract][Full Text] [Related]
17. Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity.
Kasibhatla SR; Hong K; Biamonte MA; Busch DJ; Karjian PL; Sensintaffar JL; Kamal A; Lough RE; Brekken J; Lundgren K; Grecko R; Timony GA; Ran Y; Mansfield R; Fritz LC; Ulm E; Burrows FJ; Boehm MF
J Med Chem; 2007 Jun; 50(12):2767-78. PubMed ID: 17488003
[TBL] [Abstract][Full Text] [Related]
18. Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.
He H; Zatorska D; Kim J; Aguirre J; Llauger L; She Y; Wu N; Immormino RM; Gewirth DT; Chiosis G
J Med Chem; 2006 Jan; 49(1):381-90. PubMed ID: 16392823
[TBL] [Abstract][Full Text] [Related]
19. Novel nontoxic heat shock protein 90 inhibitors having selective antiproliferative effect.
Orosz A; Szabo A; Szeman G; Janaky T; Somlai C; Penke B; Bodor A; Perczel A
Int J Biochem Cell Biol; 2006; 38(8):1352-62. PubMed ID: 16540363
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
